Merus NV
NASDAQ:MRUS

Watchlist Manager
Merus NV Logo
Merus NV
NASDAQ:MRUS
Watchlist
Price: 50.02 USD -1.79% Market Closed
Market Cap: 3.4B USD
Have any thoughts about
Merus NV?
Write Note

Merus NV
Revenue

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Merus NV
Revenue Peer Comparison

Comparables:
PHARM
PRQR
QURE
ARGX
LVTX

Competitive Revenue Analysis
Latest Figures & CAGR of Competitors

Company Revenue CAGR 3Y CAGR 5Y CAGR 10Y
Merus NV
NASDAQ:MRUS
Revenue
$35.9m
CAGR 3-Years
-6%
CAGR 5-Years
1%
CAGR 10-Years
N/A
Pharming Group NV
AEX:PHARM
Revenue
$277.6m
CAGR 3-Years
-7%
CAGR 5-Years
5%
CAGR 10-Years
51%
ProQR Therapeutics NV
NASDAQ:PRQR
Revenue
€18.7m
CAGR 3-Years
143%
CAGR 5-Years
29%
CAGR 10-Years
N/A
Uniqure NV
NASDAQ:QURE
Revenue
$28.6m
CAGR 3-Years
-61%
CAGR 5-Years
36%
CAGR 10-Years
18%
argenx SE
XBRU:ARGX
Revenue
$1.9B
CAGR 3-Years
44%
CAGR 5-Years
87%
CAGR 10-Years
126%
LAVA Therapeutics NV
NASDAQ:LVTX
Revenue
$6.8m
CAGR 3-Years
25%
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is Merus NV's Revenue?
Revenue
35.9m USD

Based on the financial report for Sep 30, 2024, Merus NV's Revenue amounts to 35.9m USD.

What is Merus NV's Revenue growth rate?
Revenue CAGR 5Y
1%

Over the last year, the Revenue growth was -21%. The average annual Revenue growth rates for Merus NV have been -6% over the past three years , 1% over the past five years .

Back to Top